H2_Analysis tables

Analysis Tables

Table Shell 1: Description of samples at baseline surveys

	Total	Intervention	Control	p-value	N
Clinic-Level
In a typical month…
Number of patients seen (mean)
Number that are female (mean)
Number of these females that are seen for routine or well-woman exams (mean)
Number of Paps performed (mean)
Provider-Level
Age (mean)
Female provider (%)
Ethnicity (%) Hispanic Non-Hispanic
Race* (%) White Black or African American Asian Native Hawaiian or other Pacific Islander Native American or Alaska Native
Type of Clinician (%) Ob/Gyn Other physician Nurse Practitioner Certified nurse midwife Physician’s Assistant
Number of years providing clinical care (mean)
Number of primary care outpatient settings where currently practice (%) 1 2 3 or more
Hours spent in direct patient care (mean)
Percent of professional time spent in: Primary care Subspecialty care Research Teaching Administration Other
Years in practice at this clinic (mean)
Hours per week spent on outpatient care at this clinic (mean)
Number of patients seen at this clinic in a typical week (mean)
Number of adult female patients seen for routine or well-woman exams in typical week (mean)
Patient-Level
Age, years (mean)
Ethnicity (%) Hispanic Non-Hispanic
Race* (%) White Black or African American Asian Native Hawaiian or other Pacific Islander Native American or Alaska Native
Nativity (%) Foreign-born US-born
Language spoken at home (%) English Other
Highest level of school (%) Less than high school High school or GED At least some college
Type of Health Insurance (%) Private Medicare Medicaid Military or VA IL BCCP No insurance / self-pay Other

* Respondents were allowed to check all racial categories that applied.

Table Shell 2: Comparison of measures across control and intervention sites, percent and mean distributions

	Baseline Survey				Follow-up Survey*
	Total	Intervention	Control	p-value	Total	Intervention	Control	p-value
Patient-Level Measures
High Risk Behavior Scale
Pap Knowledge Scale
Previous HPV Test Use
HPV Knowledge Scale
HPV Testing Today – Attitude Scale
HPV Testing Today – Beliefs Scale
Screening Interval – Attitude Scale
Screening Interval – Beliefs Scale
Screening Interval – Intention
Provider-Level Measures
Importance of Annual Exam Scale
STD exposure
HPV Experience
Previous HPV training
Follow ACOG Guidelines
HPV Testing – Attitude Scale
HPV Testing – Beliefs Scale
HPV Testing – Social Support Scale
Screening Interval with Negative HPV and Normal Pap Results…
Attitude Scale
Beliefs Scale
Social Support Scale
Screening Interval with 3 Normal Paps…
Attitude Scale
Beliefs Scale
Social Support Scale

* Follow-up data are from the 18-month Patient Survey and the 12-month Provider Survey.

Table Shell 3: Bivariate and multivariate associations with increased screening interval

	Bivariate Models		Multivariate Model
	Estimate	p-value	Estimate	p-value
Clinic-Level Measures Intervention Site Control Site (reference)
Patient-Level Measures
Age, years
Race / Ethnicity Hispanic Black, non-Hispanic Other, non-Hispanic White, non-Hispanic (reference)
Nativity Foreign-born US-born (reference)
Language spoken at home English (reference) Other
Highest level of school Less than high school High school or GED (reference) At least some college
High Risk Behavior Scale
Pap Knowledge Scale
Previous HPV Test Use
HPV Knowledge Scale
HPV Testing Today – Attitude Scale
HPV Testing Today – Beliefs Scale
Screening Interval – Attitude Scale
Screening Interval – Beliefs Scale
Screening Interval – Intention
Provider-Level Measures
Type of Provider Ob/Gyn (reference) Other physician Nurse Practitioner Certified nurse midwife Physician’s Assistant
Importance of Annual Exam Scale
Risk Assessment Scale
STD exposure
HPV Experience
Previous HPV training
Follow ACOG Guidelines
HPV Testing – Attitude Scale
HPV Testing – Belief Scale
HPV Testing – Social Support Scale
Screening Interval with Negative HPV and Normal Pap Results…
Attitude Scale
Beliefs Scale
Social Support Scale
Screening Interval with 3 Normal Paps…
Attitude Scale
Beliefs Scale
Social Support Scale

Table Shell 4: Mean and standard deviation of provider attitude, belief and social support scales across the four provider survey waves

	Baseline	12 months	24 months	36 months	p-value
HPV Testing
Attitude Scale Intervention (mean / sd) Control (mean / sd)
Belief Scale Intervention (mean / sd) Control (mean / sd)
Social Support Scale Intervention (mean / sd) Control (mean / sd)
Screening Interval with Negative HPV and Normal Pap Results…
Attitude Scale Intervention (mean / sd) Control (mean / sd)
Beliefs Scale Intervention (mean / sd) Control (mean / sd)
Social Support Intervention (mean / sd) Control (mean / sd)
Screening Interval with 3 Normal Paps…
Attitude Scale Intervention (mean / sd) Control (mean / sd)
Beliefs Scale Intervention (mean / sd) Control (mean / sd)
Social Support Intervention (mean / sd) Control (mean / sd)

Table Shell 5: Percent distribution of HPV genotype risk by age group, ethnicity and race

	High Risk HPV	Low Risk HPV	No HPV
Age group 35-39 years 40-44 45-49 50-54 55-60
Ethnicity Hispanic Non-Hispanic
Race* (%) White Black or African American Asian Native Hawaiian or other Pacific Islander Native American or Alaska Native

* Respondents were allowed to check all racial categories that applied. Racial categories will be collapsed as needed due to small cell sizes.

Table Shell 6: Type of follow-up test or procedure performed for women with positive test results, percent (N)

Type of follow-up test or procedure performed	HPV Pos / Pap Abnormal (N=)	HPV Pos / Pap Normal (N=)	HPV Neg / Pap Abnormal (N=)
Pap test
HPV DNA test
Colposcopy / Biopsy
Treatment (1)
Other diagnostic procedure (2)
No follow-up

(1) Treatment includes cone biopsy conization, cryotherapy, laser ablation, and cold knife cone.

(2) Other diagnostic procedure includes cervical ultrasound, excision of endocervical polyps, cervicography, and endometrial sampling.

Table Shell 7: Percent distribution HPV vaccine attitudes and beliefs, baseline provider survey

	Percent	N
Currently recommend the HPV vaccine
If YES, recommend HPV vaccine to the following patient.s…
Females 9-12 years of age
Females 13-26 years of age
Females 27 years of age and older
Males 9-12 years of age
Males 13-26 years of age
Males 27 years of age and older
If NO, plan to recommend the HPV vaccine
Plan to change cervical cancer screening and management for females who are fully vaccinated with HPV vaccine Yes No Don’t know
How often will you routinely screen for cervical cancer among females that have been fully vaccinated with the HPV vaccine? Annually Every 2-3 years Every 4-5 years > 5 years Will not be screened Unknown
Will use the HPV test to manage abnormal Pap results for vaccinated
Patients are asking about HPV vaccination
Vaccinating female patients will result in…
Fewer numbers of abnormal Pap tests among vaccinated females Agree Disagree Unsure
Fewer referrals for colposcopy among vaccinated females Agree Disagree Unsure
Fewer CIN results Agree Disagree Unsure

Attachment H2. Analysis tables 2